H
Healx
AI-drug discovery accelerating treatments for rare diseases
About Healx
Healx is a pioneering company in the field of AI-driven drug discovery, focusing on developing new treatments for rare diseases. The company leverages advanced artificial intelligence to identify and accelerate the development of effective therapies for conditions that affect a small percentage of the population. Healx primarily serves patients with rare diseases, their families, and healthcare providers who are in dire need of innovative treatment options. Operating within the pharmaceutical and biotechnology markets, Healx collaborates with patient groups, research institutions, and pharmaceutical companies to expand its pipeline of potential treatments. The business model revolves around partnerships and collaborations, where Healx uses its proprietary AI technology to discover and repurpose drugs, thereby reducing the time and cost associated with traditional drug development. Revenue is generated through licensing agreements, milestone payments, and royalties from successfully developed therapies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Cambridge, United Kingdom
- Employees
- 70
- Open positions
- None listed
- Dealroom signal
- 73.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Spinout, Disease, Sustainable Development Goals, Tech for Biotech and Pharma
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Deep Learning
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VCOther financing | Jul 2025 | $0 | — | SCI Ventures | ↗ |
| SERIES COther financing | Aug 2024 | $47M | $188M | Balderton Capital · b2venture · VU Venture Partners · Atomico | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Healx is 7.5K monthly website visits, up 21% over the last three months. Healx's team grew 6.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Amadeus Capital Partners
Jonathan Milner
Balderton Capital
Atomico
Intel Capital
Global Brain Corporation
b2venture
Series B and later5 investors entered at this stage
VU Venture Partners
Ayana capital
R42 Group
O2h Ventures
SCI Ventures
Other known investors4 additional known investors
Cambridge Enterprise
Pitch@Palace
Tech Nation
University of Cambridge
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Healx on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Healx’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.